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Abstract
Background: Many studies have identified various vestibular symptoms and laboratory abnormalities in migraineurs.
Although the vestibular tests may be abnormal, the changes may exist without vestibular symptoms. To date,
vestibular-evoked myogenic potential (VEMP) has been the easiest and simplest test for measuring vestibular function
in clinical practice. Cervical VEMP (cVEMP) represents a vestibulo-collic reflex, whereas ocular VEMP (oVEMP) reflects a
vestibulo-ocular pathway. Therefore, we determined whether ocular and rectified cervical VEMPs differed in patients
with migraine or tension type headache (TTH) and compared the results to controls with no accompanying vestibular
symptoms.
Methods: The present study included 38 females with migraine without aura, 30 with episodic TTH, and 50 healthy
controls without vestibular symptoms. oVEMP and cVEMP using a blood pressure manometer were recorded during a
headache-free period. From the VEMP graphs, latency and amplitude parameters were analyzed, especially following
EMG rectification in cVEMP.
Results: With respect to oVEMP, the migraine group exhibited significantly longer mean latencies of bilateral n1 and
left p1 than the other groups (p < 0.05). Amplitudes of n1-p1 were lower than in other groups, but the difference did
not reach statistical significance. In regards to cVEMP, p13 and n23 latencies and amplitudes after rectification did not
differ significantly among groups.
Conclusions: An abnormal interictal oVEMP profile was associated with subclinical vestibular dysfunction in
migraineurs, suggesting pathology within the vestibulo-ocular reflex. oVEMP is a more reliable measure than
cVEMP to evaluate vestibular function in migraineurs, although results from the two tests in patients with
migraine are complementary.
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Background
Dizziness and vertigo are frequent symptoms accom-
panying primary headache disorders, especially migraine
[1]. Migraine has long been associated with various
vestibular symptoms and several vestibular syndromes
[2]. Additionally, several studies have identified several
vestibular laboratory abnormalities in migraineurs [3].
Of the various methods used to evaluate the vestibular
system, vestibular evoked myogenic potential (VEMP) is
a non-invasive and simple clinical test. Cervical VEMP
(cVEMP) represents an uncrossed vestibulo-collic reflex,
which assesses saccular function, the inferior vestibular
nerve and vestibular nuclei, and serves as a pathway
through the lower brainstem to the motor neurons of
the sternocleidomastoid muscle [4]. The more recently
described ocular VEMP (oVEMP), a manifestation of a
crossed vestibulo-ocular pathway, reflects predominantly
utricular function and involves the medial longitudinal
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fasciculus, oculomotor nuclei and nerves, and extraocu-
lar muscles following activation of the vestibular nerve
and nucleus [4, 5]. While cVEMP descends via the vesti-
bulospinal tract through the lower brainstem, oVEMP
ascends via the medial longitudinal fasciculus through
the upper brainstem. Additionally, recent studies suggest
that oVEMP is produced by otolith afferents in the su-
perior vestibular nerve division, whereas cVEMP, evoked
by sound, is believed to be an inferior vestibular nerve
reflex [6]. Using oVEMP and cVEMP together allows for
the evaluation of both ascending and descending ves-
tibular pathways in the brainstem and identifies a higher
percentage of abnormalities [4]. Thus, the combined
measures of oVEMP and cVEMP provide complemen-
tary information.
VEMP presentation differs in individual patients ac-
cording to the method used for assessment, diagnosis
of migraine subtype, and the presence of vestibular
symptoms, as reported in literature. Several authors
have reported absent or delayed cVEMPs [7–10],
whereas others have found cVEMPs of normal latency
but reduced amplitude in migraineurs [11, 12]. In
contrast with most previous studies, a normal interic-
tal cVEMP profile was reported in patients with mi-
graine with or without aura and vestibular migraine
[13]. Recently, interest in oVEMP studies for migraine
has increased. High rates of absent oVEMP and
higher amplitude asymmetry ratios or reduced ampli-
tudes have been shown in vestibular migraine (VM)
[14, 15], whereas prolonged latency and lower ampli-
tudes were found in migraineurs without vestibular
symptoms [16].
Although previous VEMP reports have been incon-
sistent, VEMP remains the easiest and simplest
method for measuring vestibular activity in clinical
practice to date. Measurement of both ocular and
cervical VEMPs provides more information because
the results are complementary. Additionally, several
studies on patients with migraine without vestibular
symptoms have reported vestibular deficits in various
vestibular function tests. In particular, findings such
as defective oculomotor function, dysfunctional equi-
librium, and peripheral and central vestibular deficits
have been described [17–21]. Patients with tension-
type headache (TTH) often report balance disorders
or subjective imbalance [22, 23]. However, little is
known about vestibular function in those with TTH
without manifested vestibulopathy.
Thus, we hypothesized that migraineurs with no ac-
companying vestibular symptoms exhibit subclinical ves-
tibular dysfunction. We investigated vestibular function
using ocular and rectified cervical VEMP methods in
patients with migraine without aura and those with epi-
sodic TTH during headache-free periods.
Methods
Subjects
This study collected data obtained from consecutive
first-visit patients with migraine without aura and epi-
sodic TTH treated in the neurology outpatient depart-
ment of a university hospital. All participants were
between 20 and 60 years of age, and only females were
included to eliminate age and gender bias [24–26].
Headache diagnoses were classified by a board-certified
neurologist based on the criteria of the International
Classification of Headache Disorders-3 beta version
(ICHD-3β) using patient history, a neurological examin-
ation, and laboratory or neuroimaging studies. To ex-
clude other primary headaches, patients were required
to have at least a 1-year history of migraine or TTH
headaches prior to enrollment. Patients who had auras
or vestibular symptoms during headache attacks were
excluded. In total, 38 patients with migraine without
aura and 30 patients with episodic TTH based on the
ICHD-3β were enrolled in the study. Subjects with epi-
sodic TTH were defined as those with headaches lasting
from 1 to 15 days per month (frequent episodic TTH).
The control group consisted of age-matched volun-
teers. We recruited the control group by inviting per-
sons who accompanied the patients to join the study
(e.g., friends) and also through advertisements (e.g.,
posted notices in the hospital). Controls were free of
headaches for at least three months prior to the
study, experienced no more than an occasional mild
headache (<5 times per year) and had not sought
medical treatment for headaches.
All participants were underwent physical and neuro-
logical examinations performed by an experienced
neurologist. Participants were asked to complete a ques-
tionnaire regarding their headache symptoms, including
frequency, duration, and intensity, during the previous
4 weeks. Headache frequency (days/week) was calculated
by dividing the number of days with headaches by
4 weeks. Headache duration (hours/day) was calculated
by dividing the sum of the total hours of headaches
by the number of days with headaches and headache
intensity (numeric rating scale [NRS]: 0 = no pain to
10 = unbearable pain) was calculated as the mean
NRS for days with headaches. We also obtained a
comprehensive neuro-otological history from all par-
ticipants. The detailed interview for assessing vestibu-
lar symptoms in headache patients or diagnosing VM
according to the ICHD-3β included questions about
clinical features (e.g., main type of vertigo and dur-
ation, frequency, severity) and concomitant symptoms.
Exclusion criteria included subjects with hearing loss,
middle ear disease or surgery, history of vestibular
disease, history of recurrent vertigo or vertigo that
lasted more than one day or required hospitalization,
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a cervical disorder that affected head movement, the
presence of neurological disorders (e.g. stroke, multiple
sclerosis), pregnancy, daily medication to prevent head-
aches and/or antidepressant medication, medication-
overuse headache, and patients with VM.
Written informed consent was obtained from all sub-
jects prior to enrollment. The university hospital ethics
committee approved this study.
VEMP recordings
VEMP tests were performed by an examiner blinded to
group and patient clinical examination data. VEMP re-
cordings were performed using a Nicolet EDX EMP/EP
machine (Natus Neurology, Middleton, WI, USA). Pa-
tients with headache underwent VEMP testing on
headache-free days. Specifically, recordings in migraine
patients were obtained interictally at least 3 days after
the last and before the next migraine attack.
oVEMP
For oVEMP testing, the active electrode was placed ~1 cm
below the center of the inferior eyelid contralateral to
the sound stimulation, with the reference electrode
located 15 mm below the active electrode and the
ground electrode on the forehead. Patients were
tested in a seated position. During the test, patients
were asked to look upward to a fixed point 2 m away
and 25-30° above the horizontal line. Electromyog-
raphy (EMG) signals were amplified and band pass-
filtered between 30 and 3000 Hz. Sound stimuli were
presented through headphones as short tone burst
sounds (500 Hz) at a frequency of 5 Hz. In total, 100
stimuli were applied to each ear and repeated twice
consecutively at 130 dB normal hearing level (nHL).
cVEMP
For cVEMP testing, the active electrode was placed on
the upper one-third of the sternocleidomastoid (SCM)
muscle, ipsilateral to the sound stimulation, with the ref-
erence electrode on the anterior margin of the clavicle
and the ground electrode on the forehead. Patients were
tested in a seated position. To contract the SCM, we
used the blood pressure cuff method [27]. Subjects had
to flex the head ~30° forward and rotate it ~30° to the
opposite side. While holding the cuff between the right
hand and jaw, the subject pushed with her head against
the hand-held cuff to generate a cuff pressure of
40 mmHg. The obtained cuff pressures and background
muscle activity based on visual feedback system of the
VEMP machine were monitored by the subject and in-
vestigator during the recording period. EMG signals
were amplified and band pass-filtered between 20 and
2000 Hz. Sound stimuli (500 Hz) were presented
through headphones as rarefaction clicks 0.1 ms in
duration and at a frequency of 5 Hz. In total, 128 stimuli
were applied to each ear and repeated twice consecu-
tively at a 125 dB nHL.
VEMP analysis
From the oVEMP graphs, unrectified signals from 100
trials were averaged. The first negative and positive re-
sponses were designated as n1 and p1 waves, respect-
ively. The oVEMP response was only considered reliable
if the n1 and p1 peaks were reproducible in two con-
secutive trace runs. Additionally, the cVEMP response
was only considered reliable if the p13 and n23 peaks
were reproducible in two consecutive runs of the unrec-
tified trace. The p13-n23 responses were observed best
in the unrectified trace. Initial positive and negative po-
larities of the waveform with peaks were termed p13 and
n23 on the basis of their respective latencies. Rectified
values were used since the VEMP response amplitude is
significantly affected by the force of muscular contrac-
tion or stimulus intensity. After rectification (Synergy
Reader software, version 20.1), peak latencies of p13 and
n23 and amplitude parameters p13 and n23 were mea-
sured. The results of both runs were averaged, providing
the final response from which the peak-to-peak ampli-
tude (n1-p1) and absolute latencies (n1, p1) in oVEMP
and rectified amplitude and absolute latencies (p13, n23)
in cVEMP were derived. Interside differences of n1
and p1 latencies in oVEMP and p13 and n23 laten-
cies in cVEMP were calculated. Amplitude asymmetry
ratio (AR) was calculated in oVEMP and cVEMP as
follows: (larger response - smaller response) / (larger
response + smaller response) × 100 [4].
Statistical analyses
Statistical analyses were performed using ‘R’ (version
3.01; R Foundation for Statistical Computing, Vienna,
Austria) and P-values <0.05 were considered to indicate
statistical significance. The planned sample of 38 migrai-
neurs and 46 healthy subjects resulted in a power of
90 % for detecting a 40 % reduction in the bilateral
oVEMP response at a significance level of 0.05 using a
two-sided Fisher’s exact test [16]. Additionally, the sam-
ple size calculation for the t-test to detect the difference
in N1 latencies between the migraine and healthy con-
trol groups required 24 and 48 subjects, respectively.
Data were expressed as the means ± standard deviation
(SD) for continuous variables and as numbers (rates) for
categorical variables. Continuous variables were com-
pared using a two-sample t-test or Wilcoxon’s rank sum
test, whereas categorical variables were evaluated using
the χ2 test or Fisher’s exact test. Results of oVEMP
and cVEMP parameters were compared among three
subgroups. Multiple group analyses were performed
using one-way analysis of variance (ANOVA) or the
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Kruskal-Wallis test. Pair-wise comparisons were assessed




The present study included 38 females with migraine
without aura, 30 episodic TTH and 50 healthy controls.
Mean age in the migraine, TTH and control groups was
35.5, 33.3 and 35.1 years, respectively. The mean age did
not differ significantly among groups. Clinical and head-
ache characteristics are shown in Table 1.
oVEMP abnormalities
Eight patients in the migraine group (7, 18.4 % unilat-
eral; 1, 2.6 % bilateral) demonstrated absent oVEMP re-
sponses, while responses could not be obtained for three
patients in the TTH group (2, 6.7 % unilateral; 1, 3.3 %
bilateral) and five patients in the control group (3, 6.0 %
unilateral; 2, 4.0 % bilateral). A low response rate was
observed in migraineurs, but no statistical difference was
detected in the response rate of oVEMP among groups
(Table 2). In oVEMP, the migraine group had mean la-
tencies of bilateral n1 and left p1 significantly longer
than the other groups (p < 0.05). Mean amplitudes of
n1-p1 were lower than in the other groups, but the dif-
ference did not reach statistical significance (Table 3).
No significant difference was observed in the AR ampli-
tude or interaural latency differences of oVEMP. Illus-
trated examples of oVEMP tracings in controls and
patients with migraine are shown in Fig. 1. Box plots of
statistically significant oVEMP parameters are shown in
Fig. 2.
cVEMP abnormalities
Four patients in the migraine group (4, 10.5 % unilateral;
0, 0 % bilateral), seven patients in the TTH group (7,
23.3 % unilateral; 0, 0 % bilateral) and four patients
(3, 6.0 % unilateral; 1, 2.0 % bilateral) in the control
group showed absent cVEMP responses. There was
no statistically significant difference among the groups
with respect to cVEMP response rate (Table 2).
Illustrated examples of rectified cVEMP tracings in
controls and patients with migraine are shown in
Fig. 1. Additionally, p13 and n23 latencies and recti-
fied amplitudes of cVEMP in migraine without aura
and TTH patients did not differ significantly from
those of healthy controls (Table 4). Moreover, no sig-
nificant difference was observed in the amplitude AR
or interaural latency differences of cVEMP.
Discussion
In our study, significantly prolonged latency in oVEMP
was detected in migraine without aura versus TTH and








Age (years) 33.37 ± 13.70 35.58 ± 12.26 35.14 ± 13.47 NS
Frequency (day/week) 1.52 ± 0.93 2.14 ± 2.05 -
Duration (hours/day) 5.35 ± 6.01 9.51 ± 8.83 -
Intensity (NRS) 4.13 ± 1.61 6.29 ± 2.10 -
Values are expressed as mean ± standard deviation
TTH tension-type headache, NRS numeric rating scale, NS non-significant









Bilateral response, n (%) 27 (90.0 %) 30 (78.9 %) 45 (90.0 %)
Unilateral response, n (%) 2 (6.7 %) 7 (18.4 %) 3 (6.0 %)
No response, n (%) 1 (3.3 %) 1 (2.6 %) 2 (4.0 %)
cVEMP
Bilateral response, n (%) 23 (76.7 %) 34 (89.5 %) 46 (92.0 %)
Unilateral response, n (%) 7 (23.3 %) 4 (10.5 %) 3 (6.0 %)
No response, n (%) 0 (0 %) 0 (0 %) 1 (2.0 %)
TTH tension-type headache, oVEMP ocular vestibular evoked myogenic potential,
cVEMP cervical vestibular evoked myogenic potential
Table 3 oVEMP results of headache patients and healthy
controls
Parameters TTH Migraine Controls
Left side
latency n1 (ms) 11.29 ± 0.78** 12.34 ± 1.43*,** 11.29 ± 0.73*
latency p1 (ms) 16.09 ± 0.83 17.05 ± 1.95* 16.11 ± 0.82*
n1-p1 interpeak latency (ms) 4.79 ± 0.87 4.75 ± 1.22 4.82 ± 0.92
n1-p1 amplitude 11.64 ± 6.73 8.00 ± 5.21+ 11.66 ± 9.14
Right side
latency n1 (ms) 11.42 ± 0.86** 12.41 ± 1.41*,** 11.58 ± 0.90*
latency p1 (ms) 16.41 ± 0.89 16.99 ± 2.02 16.20 ± 1.04
n1-p1 interpeak latency (ms) 4.99 ± 1.02 4.58 ± 1.24 4.62 ± 1.00
n1-p1 amplitude 11.29 ± 6.77 7.51 ± 4.47+ 11.76 ± 10.79
Interside difference
interaural latency diff., n1 0.64 ± 0.86 0.91 ± 0.97 0.74 ± 0.72
interaural latency diff., p1 0.64 ± 0.55 0.84 ± 0.95 0.78 ± 0.62
amp. asymmetry ratio, n1 0.23 ± 0.17 0.28 ± 0.17 0.23 ± 0.16
amp. asymmetry ratio, n1 0.22 ± 0.19 0.28 ± 0.21 0.24 ± 0.15
*p < 0.05, statistically significant between patients with migraine and controls;
**p < 0.05, statistically significant between patients with migraine and patients
with TTH; values are expressed as the means ± standard deviation
TTH tension-type headache, oVEMP ocular vestibular-evoked myogenic potential,
amp amplitude











Fig. 1 oVEMP and rectified cVEMP responses in normal subjects (a-1, b-1, respectively) and migraine patients (a-2, b-2, respectively). oVEMP: ocular
vestibular evoked myogenic potential; cVEMP: cervical vestibular evoked myogenic potential
* p < 0.05† p < 0.05
* p < 0.05
* p < 0.05† p < 0.05
A B C
Fig. 2 Box plots of latency of oVEMP. Latencies of a left n1, b left p1, and c right n1. Horizontal dashed lines indicate the grand average. *p < 0.05,
statistically significant difference between migraine patients and healthy controls; † p < 0.05, statistically significant difference between migraine
patients and patients with TTH; oVEMP: ocular vestibular evoked myogenic potential
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control groups. However, there was no significant differ-
ence in cVEMP parameters among the migraine, TTH
and control groups. These results suggest pathology
within the oVEMP pathway or the ascending utriculo-
ocular reflex in migraineurs. Thus, migraineurs showed
subclinical vestibulopathies with oVEMP abnormalities
during a headache-free period.
cVEMP and oVEMP provide valuable information re-
garding the location and nature of the lesion(s) affecting
central vestibular pathways because the vestibulo-
collic and vestibulo-ocular reflex pathways diverge be-
yond the nerve root entry zone [4, 28]. Using oVEMP
and cVEMP together allows for the evaluation of both
ascending and descending vestibular pathways, result-
ing in the identification of a higher percentage of ab-
normalities [4, 28–30]. Patients who have brainstem
involvement in multiple sclerosis or internuclear oph-
thalmoplegia show higher abnormality rates in oVEMP
than in cVEMP [29, 31]. Additionally, oVEMP is more
sensitive than cVEMP for detecting silent brainstem
lesions in multiple sclerosis patients and vestibular
dysfunction in VM patients [14, 29]. Furthermore, be-
cause oVEMP latencies are dependent primarily on
afferent and efferent reflex limbs and central trans-
mission, prolonged latencies are likely due to the deg-
radation of central vestibular processing of otolith
signals rather than a decline in peripheral vestibular
function [26]. VEMP amplitudes can be used as inde-
pendent quantitative measures of otolith function [4].
Thus, peripheral vestibular disorders frequently in-
volve an absence of oVEMPs or decreased amplitudes,
whereas prolonged latencies may indicate central ves-
tibular lesions [32]. Significantly prolonged oVEMP
latencies in our study suggest an underlying func-
tional abnormality in the central vestibular system.
Herein, bilaterally or unilaterally absent oVEMP re-
sponses were observed in 21 % of patients in the mi-
graine group, while absent cVEMP responses were
found in 10.5 % of patients in the migraine group. Sev-
eral previous reports showed absent oVEMP responses
in the migraine group (53.3 %) and VM group (28 %),
whereas absent cVEMP responses were detected in 8 %
of VM patients [14, 16]. Similar to previous studies, a
high unresponsive rate of oVEMP in migraineurs was
observed in our study, although the difference did not
reach statistical significance. These findings also suggest
defective oVEMP pathways in migraineurs.
Various vestibular function test studies have been con-
ducted on patients with migraines during the interictal
period. Several works reported vestibular abnormalities
in the form of involvement of peripheral or central ves-
tibular pathways or both [18, 19, 33]. One study re-
ported dysfunction in the vestibulo-ocular reflex,
whereas another indicated underlying dysfunction in the
vestibulospinal system [21, 34]. Other reports showed
interictal dysfunction of vestibulocerebellar origin in
migraineurs [20, 35]. These findings suggest that
migraineurs without vestibular symptoms exhibit ves-
tibular abnormalities, generally indicating subclinical
vestibulopathies in patients with migraines. Addition-
ally, the distribution between central and peripheral
vestibular findings did not differ between VM and mi-
graine patients [18]. More recently, in a report evalu-
ating cVEMP and oVEMP pathways in patients with
VM, the rates of abnormal oVEMPs were significantly
higher without cVEMP abnormalities, similar to our
study, although the subjects suffered symptoms on
the same day of testing [14]. Thus, subclinical vestibular
dysfunction may be an integral part of migraine patho-
physiology and could be related to fundamental patho-
physiological similarities between migraine and VM.
Recently, positron emission tomography (PET) studies
have demonstrated thalamo-cortical involvement or in-
creased thalamic activation in VM patients [36, 37].
Additionally, voxel-based morphometry studies have
identified gray matter volume reductions in patients
with VM [38]. These functional and structural alter-
ations in patients with VM resemble those previously
described in patients with migraine. VM likely repre-
sents the pathophysiological paradigm of a connection
between migraine and the vestibular system [39].
Subclinical vestibulopathy in migraineurs may be re-
lated to multiple potential interactions between the tri-
geminal and vestibular systems at various levels. In
migraine patients, stimulation of the trigeminal nuclei
has produced spontaneous nystagmus [40]. Conversely,
vestibular nuclei receive both serotonergic inputs from
the dorsal raphe nucleus and noradrenergic inputs from
the locus coeruleus, and activation of these pain
Table 4 Rectified cVEMP results of headache patients and
controls
Parameters TTH Migraine Controls P value
Left side
latency p13 (ms) 12.78 ± 1.37 13.57 ± 2.37 12.84 ± 1.81 NS
latency n23 (ms) 20.82 ± 2.01 21.98 ± 3.01 21.32 ± 2.06 NS
p13 rectified amp (μV) 42.43 ± 19.10 38.61 ± 24.95 39.41 ± 21.81 NS
n23 rectified amp (μV) 53.22 ± 13.90 58.52 ± 37.73 50.95 ± 34.25 NS
Right side
latency p13 (ms) 12.89 ± 2.45 13.68 ± 2.16 13.01 ± 2.00 NS
latency n23 (ms) 21.06 ± 2.17 22.09 ± 3.10 21.56 ± 2.29 NS
p13 rectified amp (μV) 38.97 ± 21.05 34.49 ± 23.40 41.79 ± 25.55 NS
n23 rectified amp (μV) 49.98 ± 15.70 46.38 ± 28.37 57.79 ± 39.72 NS
Values are expressed as the means ± standard deviation
TTH tension-type headache, cVEMP cervical vestibular evoked myogenic potential,
amp amplitude, NS non-significant
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structures during migraine can affect central vestibular
processing [3]. These reciprocal connections between
the vestibular nuclei and trigeminal nucleus caudalis
may provide a mechanism whereby vestibular signals in-
fluence trigeminovascular pathways and trigeminal infor-
mation processing during migraine attacks [41].
Additionally, studies using functional MRI showed that
the vestibular system is represented at a cortical level
[42]. The presence of descending cortical projections on
vestibular nuclei has been demonstrated in cats. Re-
searchers concluded that neurons in cortical areas were
able to modulate vestibular reflexes [43]. Minor cere-
bellar abnormalities related to eye and arm movements
have also been described in asymptomatic migraine
patients [20, 35]. Although semicircular canal and
otolith afferents terminate in the vestibular nuclei re-
gion, both inputs project to the caudal vermis of the
cerebellum and Purkinje cells in the cortex of the
nodulus/uvula inhibit the vestibular nuclei [44]. These
various potential interconnections between migraine and
the vestibular system can cause abnormalities in vestibular
function tests in migraineurs during the interictal period.
A recent blood oxygen level-dependent (BOLD) func-
tional MRI study conducted in patients with VM, patients
with migraine without aura, and healthy controls during
the interictal period, revealed that caloric vestibular stimu-
lation elicited statistically significant activation in the
bilateral insular cortex, thalamus, cerebellum, and brain-
stem of all subjects [36]. In particular, discrete activation
in the periaqueductal gray matter was observed in
migraine patients, suggesting a peculiar relationship
between vestibular stimulation and the activation of brain
areas that play key roles in pain processing [45]. This
reciprocal connection between brainstem vestibular nuclei
and structures involved in modulation of trigeminal
nociceptive inputs may explain the VEMP abnormalities
in migraineurs.
Due to the measurement method and/or technical
factors, oVEMP is more valuable in assessing vestibular
function in patients with headache compared to cVEMP.
During cVEMP recordings, amplitude-related parame-
ters change according to the degree of tonic contraction
of the SCM showing a direct correlation; the more tonic
the muscle tension, the larger the cVEMP amplitude
response [4]. Decreased response rate and amplitude or
prolonged latencies on cVEMP and oVEMP occur with
age increase over 60 years [24, 26]. Regarding the influ-
ence of gender on oVEMPs, one study found oVEMPs
to be independent of gender [31], whereas another study
reported that the mean oVEMP amplitude in males was
significantly larger than in females [25]. Thus, in our
study, we only included females 20–60 years of age
based on these known age and gender effects. To control
the amount of muscle tension between right and left
muscles, we used a feedback method with a blood pres-
sure manometer and analyzed VEMP parameters follow-
ing EMG rectification in cVEMP [27, 46]. Many
patients with primary headache disorders, such as
TTH and migraine, also have accompanying peri-
cranial, neck and shoulder muscle tenderness and/or
associated myofascial pain syndrome. These condi-
tions can affect muscle tension or posture during
cVEMP measurements. Thus, the cVEMP method
may provide inaccurate information in patients with
migraine and TTH because the degree of muscle con-
traction affects the cVEMP result and its interpret-
ation. Consequently, oVEMP may be the more
sensitive method for evaluating the vestibular system
in primary headache disorders.
Our study had several limitations. First, highly se-
lected patients from a neurology clinic at a regional
university hospital were recruited. The sample size
was small, and the study used a cross-sectional design
that provided limited causal information. Second, the
present data did not identify statistically significant
correlations between VEMP parameters and headache
clinical parameters such as frequency, duration, and
intensity (data not shown). Additionally, this study
was based on outpatient subjects and only adminis-
tered the headache questionnaire at the first visit;
therefore, detailed headache characteristics recorded
using a headache diary should be considered in future
studies to more accurately identify the correlations
between electrophysiological data and headache pa-
rameters. Furthermore, prospective longitudinal studies
including information regarding impact or disabilities
due to headache may be warranted. Third, sound
stimulation was applied at 500 Hz, which showed a
100 % response rate in both oVEMP and cVEMP of
healthy subjects [47]. However, VEMPs were not ob-
tained in approximately 8-10 % of subjects in the
control group, as previous studies showed similar results
[14, 16]. oVEMP and cVEMP predominantly represent
saccular stimulation, and bone vibration activates both ut-
ricular and saccular afferents [4]. Thus, we should con-
sider the use of a bone vibrator in future studies.
Conclusions
In conclusion, this study provides electrophysiological
evidence that abnormalities of the oVEMP pathway can
be observed in patients with migraine without aura who
are not experiencing vestibular symptoms during a
headache-free period. These findings appear to be re-
lated to subclinical vestibulopathy in migraineurs. Thus,
oVEMP may be useful in evaluating alterations in the
vestibular system in patients with migraine as well as
other types of primary headaches.
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